Table of Content

1 INTRODUCTION 41
1.1 STUDY OBJECTIVES 41
1.2 MARKET DEFINITION 41
1.2.1 INCLUSIONS & EXCLUSIONS 42
1.3 MARKET SCOPE 42
FIGURE 1 LIVE CELL IMAGING MARKET SEGMENTATION 42
1.3.1 YEARS CONSIDERED 43
1.4 CURRENCY 43
1.5 LIMITATIONS 43
1.6 STAKEHOLDERS 44
1.7 SUMMARY OF CHANGES 44
1.7.1 RECESSION IMPACT 45
2 RESEARCH METHODOLOGY 46
2.1 RESEARCH DATA 46
FIGURE 2 RESEARCH DESIGN 46
2.1.1 SECONDARY DATA 47
2.1.2 PRIMARY DATA 47
FIGURE 3 LIVE CELL IMAGING MARKET: BREAKDOWN OF PRIMARIES 48
2.2 MARKET SIZE ESTIMATION 49
FIGURE 4 MARKET SIZE ESTIMATION: SUPPLY-SIDE ANALYSIS, 2022 49
FIGURE 5 MARKET SIZE ESTIMATION: APPROACH 1 (REVENUE SHARE ANALYSIS), 2022 50
FIGURE 6 ILLUSTRATIVE EXAMPLE OF DANAHER CORPORATION: REVENUE SHARE ANALYSIS, 2022 51
2.2.1 INSIGHTS FROM PRIMARIES 52
FIGURE 7 MARKET VALIDATION FROM PRIMARY EXPERTS 52
FIGURE 8 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH 52
2.3 GROWTH FORECAST 53
FIGURE 9 LIVE CELL IMAGING MARKET: CAGR PROJECTIONS, 2022–2028 54
FIGURE 10 LIVE CELL IMAGING MARKET: GROWTH ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 54
2.4 MARKET BREAKDOWN AND DATA TRIANGULATION 55
FIGURE 11 DATA TRIANGULATION METHODOLOGY 55
2.5 RESEARCH ASSUMPTIONS 56
2.6 RISK ANALYSIS 56
2.7 RECESSION IMPACT ON LIVE CELL IMAGING MARKET 56
TABLE 1 GLOBAL INFLATION RATE PROJECTIONS, 2021–2027 (% GROWTH) 57
TABLE 2 US HEALTH EXPENDITURE, 2019–2022 (USD MILLION) 57
TABLE 3 US HEALTH EXPENDITURE, 2023–2027 (USD MILLION) 57
3 EXECUTIVE SUMMARY 59
FIGURE 12 LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE, 2023 VS. 2028 (USD MILLION) 59
FIGURE 13 LIVE CELL IMAGING MARKET, BY APPLICATION, 2023 VS. 2028 (USD MILLION) 60
FIGURE 14 LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2023 VS. 2028 (USD MILLION) 60
FIGURE 15 LIVE CELL IMAGING MARKET, BY END USER, 2023 VS. 2028 (USD MILLION) 61
FIGURE 16 GEOGRAPHICAL SNAPSHOT OF LIVE CELL IMAGING MARKET 62
4 PREMIUM INSIGHTS 63
4.1 LIVE CELL IMAGING MARKET OVERVIEW 63
FIGURE 17 GROWING ADOPTION OF HIGH-CONTENT SCREENING TECHNIQUES IN DRUG DISCOVERY TO DRIVE MARKET GROWTH 63
4.2 NORTH AMERICA: LIVE CELL IMAGING MARKET SHARE, BY PRODUCT & SERVICE AND COUNTRY (2022) 64
FIGURE 18 INSTRUMENTS DOMINATED NORTH AMERICAN LIVE CELL IMAGING MARKET IN 2022 64
4.3 LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE, 2023 VS. 2028 (USD MILLION) 65
FIGURE 19 INSTRUMENTS TO CONTINUE TO DOMINATE MARKET BY 2028 65
4.4 LIVE CELL IMAGING MARKET SHARE, BY END USER, 2022 65
FIGURE 20 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES ACCOUNTED FOR LARGEST MARKET SHARE IN 2022 65
4.5 LIVE CELL IMAGING MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 66
FIGURE 21 ASIA PACIFIC TO REGISTER HIGHEST GROWTH RATE IN LIVE CELL IMAGING MARKET FROM 2023 TO 2028 66
5 MARKET OVERVIEW 67
5.1 INTRODUCTION 67
5.2 MARKET DYNAMICS 67
FIGURE 22 LIVE CELL IMAGING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 67
TABLE 4 LIVE CELL IMAGING MARKET: IMPACT ANALYSIS 68
5.2.1 DRIVERS 68
5.2.1.1 Growing adoption of high-content screening techniques in drug discovery 68
5.2.1.2 Rising incidence of cancer 69
TABLE 5 ESTIMATED NEW CANCER CASES IN US, 2023 69
FIGURE 23 GLOBAL CANCER INCIDENCE & MORTALITY, 2020 70
5.2.1.3 Growing availability of research funds 70
TABLE 6 INVESTMENT BREAKDOWN, 2021 (USD MILLION) 72
5.2.2 RESTRAINTS 72
5.2.2.1 High cost of high-content screening systems 72
5.2.3 OPPORTUNITIES 73
5.2.3.1 Increasing adoption of live cell imaging technologies in emerging economies 73
5.2.3.2 Applications of HCS in personalized medicine 73
5.2.4 CHALLENGES 74
5.2.4.1 Maintaining cell viability and cellular environment in cell cultures 74
5.2.4.2 Image analysis and data management 74
5.3 TECHNOLOGY ANALYSIS 75
5.4 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 76
FIGURE 24 REVENUE SHIFT & NEW POCKETS FOR LIVE CELL IMAGING PRODUCT & SERVICE PROVIDERS 77
5.5 VALUE/SUPPLY CHAIN ANALYSIS 77
5.5.1 VALUE CHAIN ANALYSIS 77
FIGURE 25 LIVE CELL IMAGING MARKET: VALUE CHAIN ANALYSIS 78
5.5.2 SUPPLY CHAIN ANALYSIS 79
FIGURE 26 LIVE CELL IMAGING MARKET: SUPPLY CHAIN ANALYSIS 79
5.6 REGULATORY ANALYSIS 80
5.6.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 80
5.6.1.1 North America 80
5.6.1.1.1 US 80
5.6.1.1.2 Canada 80
5.6.1.2 Europe 80
5.6.1.3 Asia Pacific 81
5.6.1.4 Rest of the World 81
5.7 PORTER’S FIVE FORCES ANALYSIS 82
TABLE 7 LIVE CELL IMAGING MARKET: PORTER’S FIVE FORCES ANALYSIS 82
5.7.1 THREAT OF NEW ENTRANTS 82
5.7.2 THREAT OF SUBSTITUTES 82
5.7.3 BARGAINING POWER OF SUPPLIERS 82
5.7.4 BARGAINING POWER OF BUYERS 82
5.7.5 INTENSITY OF COMPETITIVE RIVALRY 83
5.8 ECOSYSTEM ANALYSIS 83
TABLE 8 SUPPLY CHAIN ECOSYSTEM 83
5.9 PRICING ANALYSIS 85
5.9.1 AVERAGE SELLING PRICE, BY KEY PLAYER 85
TABLE 9 AVERAGE SELLING PRICES 85
5.9.2 AVERAGE SELLING PRICE TREND 86
5.10 KEY CONFERENCES & EVENTS IN 2022–2023 86
TABLE 10 LIVE CELL IMAGING: DETAILED LIST OF CONFERENCES & EVENTS 86
5.11 KEY STAKEHOLDERS AND BUYING CRITERIA 88
5.11.1 KEY STAKEHOLDERS IN BUYING PROCESS 88
FIGURE 27 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF LIVE CELL IMAGING PRODUCTS 88
5.11.2 BUYING CRITERIA FOR LIVE CELL IMAGING 88
FIGURE 28 KEY BUYING CRITERIA FOR END USERS 88
5.12 PATENT ANALYSIS 89
FIGURE 29 LIVE CELL IMAGING MARKET: PATENT APPLICATIONS (JANUARY 2020–APRIL 2023) 89
6 LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE 90
6.1 INTRODUCTION 91
TABLE 11 LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 91
6.2 INSTRUMENTS 92
TABLE 12 EXAMPLES OF INSTRUMENTS OFFERED BY MARKET PLAYERS 92
TABLE 13 LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 93
TABLE 14 LIVE CELL IMAGING INSTRUMENTS MARKET, BY REGION, 2021–2028 (USD MILLION) 93
TABLE 15 NORTH AMERICA: LIVE CELL IMAGING INSTRUMENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 93
TABLE 16 EUROPE: LIVE CELL IMAGING INSTRUMENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 94
TABLE 17 ASIA PACIFIC: LIVE CELL IMAGING INSTRUMENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 94
TABLE 18 LATIN AMERICA: LIVE CELL IMAGING INSTRUMENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 94
6.2.1 MICROSCOPES 95
6.2.1.1 Continuous technological advancements in microscopes to support market 95
TABLE 19 CONVENTIONAL MICROSCOPES OFFERED BY KEY MARKET PLAYERS 96
TABLE 20 CONFOCAL MICROSCOPES OFFERED BY KEY MARKET PLAYERS 97
TABLE 21 FLUORESCENCE MICROSCOPES OFFERED BY KEY MARKET PLAYERS 98
TABLE 22 LIVE CELL IMAGING INSTRUMENTS MARKET FOR MICROSCOPES, BY REGION, 2021–2028 (USD MILLION) 98
TABLE 23 NORTH AMERICA: LIVE CELL IMAGING INSTRUMENTS MARKET FOR MICROSCOPES, BY COUNTRY, 2021–2028 (USD MILLION) 99
TABLE 24 EUROPE: LIVE CELL IMAGING INSTRUMENTS MARKET FOR MICROSCOPES, BY COUNTRY, 2021–2028 (USD MILLION) 99
TABLE 25 ASIA PACIFIC: LIVE CELL IMAGING INSTRUMENTS MARKET FOR MICROSCOPES, BY COUNTRY, 2021–2028 (USD MILLION) 99
TABLE 26 LATIN AMERICA: LIVE CELL IMAGING INSTRUMENTS MARKET FOR MICROSCOPES, BY COUNTRY, 2021–2028 (USD MILLION) 100
6.2.2 STANDALONE SYSTEMS 100
6.2.2.1 Seamless integration and workflow efficiency of standalone systems to boost demand 100
TABLE 27 STANDALONE SYSTEMS OFFERED BY KEY MARKET PLAYERS 100
TABLE 28 LIVE CELL IMAGING INSTRUMENTS MARKET FOR STANDALONE SYSTEMS, BY REGION, 2021–2028 (USD MILLION) 101
TABLE 29 NORTH AMERICA: LIVE CELL IMAGING INSTRUMENTS MARKET FOR STANDALONE SYSTEMS, BY COUNTRY, 2021–2028 (USD MILLION) 101
TABLE 30 EUROPE: LIVE CELL IMAGING INSTRUMENTS MARKET FOR STANDALONE SYSTEMS, BY COUNTRY, 2021–2028 (USD MILLION) 101
TABLE 31 ASIA PACIFIC: LIVE CELL IMAGING INSTRUMENTS MARKET FOR STANDALONE SYSTEMS, BY COUNTRY, 2021–2028 (USD MILLION) 102
TABLE 32 LATIN AMERICA: LIVE CELL IMAGING INSTRUMENTS MARKET FOR STANDALONE SYSTEMS, BY COUNTRY, 2021–2028 (USD MILLION) 102
6.2.3 CELL ANALYZERS 102
6.2.3.1 Accuracy and reproducibility of cell analyzers to support growth 102
TABLE 33 CELL ANALYZERS OFFERED BY KEY MARKET PLAYERS 103
TABLE 34 LIVE CELL IMAGING INSTRUMENTS MARKET FOR CELL ANALYZERS, BY REGION, 2021–2028 (USD MILLION) 103
TABLE 35 NORTH AMERICA: LIVE CELL IMAGING INSTRUMENTS MARKET FOR CELL ANALYZERS, BY COUNTRY, 2021–2028 (USD MILLION) 103
TABLE 36 EUROPE: LIVE CELL IMAGING INSTRUMENTS MARKET FOR CELL ANALYZERS, BY COUNTRY, 2021–2028 (USD MILLION) 104
TABLE 37 ASIA PACIFIC: LIVE CELL IMAGING INSTRUMENTS MARKET FOR CELL ANALYZERS, BY COUNTRY, 2021–2028 (USD MILLION) 104
TABLE 38 LATIN AMERICA: LIVE CELL IMAGING INSTRUMENTS MARKET FOR CELL ANALYZERS, BY COUNTRY, 2021–2028 (USD MILLION) 104
6.2.4 ACCESSORIES 105
6.2.4.1 Ability of accessories to optimize and enhance imaging conditions to boost demand 105
TABLE 39 ACCESSORIES OFFERED BY KEY MARKET PLAYERS 105
TABLE 40 LIVE CELL IMAGING INSTRUMENTS MARKET FOR ACCESSORIES, BY REGION, 2021–2028 (USD MILLION) 106
TABLE 41 NORTH AMERICA: LIVE CELL IMAGING INSTRUMENTS MARKET FOR ACCESSORIES, BY COUNTRY, 2021–2028 (USD MILLION) 106
TABLE 42 EUROPE: LIVE CELL IMAGING INSTRUMENTS MARKET FOR ACCESSORIES, BY COUNTRY, 2021–2028 (USD MILLION) 107
TABLE 43 ASIA PACIFIC: LIVE CELL IMAGING INSTRUMENTS MARKET FOR ACCESSORIES, BY COUNTRY, 2021–2028 (USD MILLION) 107
TABLE 44 LATIN AMERICA: LIVE CELL IMAGING INSTRUMENTS MARKET FOR ACCESSORIES, BY COUNTRY, 2021–2028 (USD MILLION) 107
6.3 CONSUMABLES 108
TABLE 45 LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION) 108
TABLE 46 LIVE CELL IMAGING CONSUMABLES MARKET, BY REGION, 2021–2028 (USD MILLION) 108
TABLE 47 NORTH AMERICA: LIVE CELL IMAGING CONSUMABLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 109
TABLE 48 EUROPE: LIVE CELL IMAGING CONSUMABLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 109
TABLE 49 ASIA PACIFIC: LIVE CELL IMAGING CONSUMABLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 109
TABLE 50 LATIN AMERICA: LIVE CELL IMAGING CONSUMABLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 110
6.3.1 REAGENTS 110
6.3.1.1 Widespread usage in life science research to fuel market growth 110
TABLE 51 REAGENTS OFFERED BY KEY MARKET PLAYERS 111
TABLE 52 LIVE CELL IMAGING CONSUMABLES MARKET FOR REAGENTS, BY REGION, 2021–2028 (USD MILLION) 111
TABLE 53 NORTH AMERICA: LIVE CELL IMAGING CONSUMABLES MARKET FOR REAGENTS, BY COUNTRY, 2021–2028 (USD MILLION) 112
TABLE 54 EUROPE: LIVE CELL IMAGING CONSUMABLES MARKET FOR REAGENTS, BY COUNTRY, 2021–2028 (USD MILLION) 112
TABLE 55 ASIA PACIFIC: LIVE CELL IMAGING CONSUMABLES MARKET FOR REAGENTS, BY COUNTRY, 2021–2028 (USD MILLION) 112
TABLE 56 LATIN AMERICA: LIVE CELL IMAGING CONSUMABLES MARKET FOR REAGENTS, BY COUNTRY, 2021–2028 (USD MILLION) 113
6.3.2 ASSAY KITS 113
6.3.2.1 Repeat purchase of assay kits to drive market 113
TABLE 57 ASSAY KITS OFFERED BY KEY MARKET PLAYERS 113
TABLE 58 LIVE CELL IMAGING CONSUMABLES MARKET FOR ASSAY KITS, BY REGION, 2021–2028 (USD MILLION) 114
TABLE 59 NORTH AMERICA: LIVE CELL IMAGING CONSUMABLES MARKET FOR ASSAY KITS, BY COUNTRY, 2021–2028 (USD MILLION) 114
TABLE 60 EUROPE: LIVE CELL IMAGING CONSUMABLES MARKET FOR ASSAY KITS, BY COUNTRY, 2021–2028 (USD MILLION) 115
TABLE 61 ASIA PACIFIC: LIVE CELL IMAGING CONSUMABLES MARKET FOR ASSAY KITS, BY COUNTRY, 2021–2028 (USD MILLION) 115
TABLE 62 LATIN AMERICA: LIVE CELL IMAGING CONSUMABLES MARKET FOR ASSAY KITS, BY COUNTRY, 2021–2028 (USD MILLION) 115
6.3.3 MEDIA 116
6.3.3.1 Increasing demand for optimized cell culture conditions to drive demand for media 116
TABLE 63 MEDIA OFFERED BY KEY MARKET PLAYERS 116
TABLE 64 LIVE CELL IMAGING CONSUMABLES MARKET FOR MEDIA, BY REGION, 2021–2028 (USD MILLION) 116
TABLE 65 NORTH AMERICA: LIVE CELL IMAGING CONSUMABLES MARKET FOR MEDIA, BY COUNTRY, 2021–2028 (USD MILLION) 117
TABLE 66 EUROPE: LIVE CELL IMAGING CONSUMABLES MARKET FOR MEDIA, BY COUNTRY, 2021–2028 (USD MILLION) 117
TABLE 67 ASIA PACIFIC: LIVE CELL IMAGING CONSUMABLES MARKET FOR MEDIA, BY COUNTRY, 2021–2028 (USD MILLION) 117
TABLE 68 LATIN AMERICA: LIVE CELL IMAGING CONSUMABLES MARKET FOR MEDIA, BY COUNTRY, 2021–2028 (USD MILLION) 118
6.3.4 OTHER CONSUMABLES 118
TABLE 69 OTHER CONSUMABLES OFFERED BY KEY MARKET PLAYERS 119
TABLE 70 OTHER LIVE CELL IMAGING CONSUMABLES MARKET, BY REGION, 2021–2028 (USD MILLION) 119
TABLE 71 NORTH AMERICA: OTHER LIVE CELL IMAGING CONSUMABLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 119
TABLE 72 EUROPE: OTHER LIVE CELL IMAGING CONSUMABLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 120
TABLE 73 ASIA PACIFIC: OTHER LIVE CELL IMAGING CONSUMABLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 120
TABLE 74 LATIN AMERICA: OTHER LIVE CELL IMAGING CONSUMABLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 120
6.4 SOFTWARE 121
6.4.1 TECHNOLOGICAL ADVANCEMENTS IN IMAGE ACQUISITION TO BOOST MARKET GROWTH 121
TABLE 75 SOFTWARE OFFERED BY KEY MARKET PLAYERS 121
TABLE 76 LIVE CELL IMAGING SOFTWARE MARKET, BY REGION, 2021–2028 (USD MILLION) 122
TABLE 77 NORTH AMERICA: LIVE CELL IMAGING SOFTWARE MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 122
TABLE 78 EUROPE: LIVE CELL IMAGING SOFTWARE MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 123
TABLE 79 ASIA PACIFIC: LIVE CELL IMAGING SOFTWARE MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 123
TABLE 80 LATIN AMERICA: LIVE CELL IMAGING SOFTWARE MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 123
6.5 SERVICES 124
6.5.1 GROWING DEMAND FOR OUTSOURCED EXPERTISE AND SPECIALIZED SERVICES TO SUPPORT MARKET 124
TABLE 81 LIVE CELL IMAGING SERVICES MARKET, BY REGION, 2021–2028 (USD MILLION) 124
TABLE 82 NORTH AMERICA: LIVE CELL IMAGING SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 125
TABLE 83 EUROPE: LIVE CELL IMAGING SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 125
TABLE 84 ASIA PACIFIC: LIVE CELL IMAGING SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 125
TABLE 85 LATIN AMERICA: LIVE CELL IMAGING SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 126
7 LIVE CELL IMAGING MARKET, BY APPLICATION 127
7.1 INTRODUCTION 128
TABLE 86 LIVE CELL IMAGING MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 128
7.2 CELL BIOLOGY 128
TABLE 87 NUMBER OF NEW CANCER CASES, BY TYPE, 2020 VS. 2040 129
TABLE 88 LIVE CELL IMAGING MARKET FOR CELL BIOLOGY APPLICATIONS, BY REGION, 2021–2028 (USD MILLION) 130
TABLE 89 NORTH AMERICA: LIVE CELL IMAGING MARKET FOR CELL BIOLOGY APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 130
TABLE 90 EUROPE: LIVE CELL IMAGING MARKET FOR CELL BIOLOGY APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 130
TABLE 91 ASIA PACIFIC: LIVE CELL IMAGING MARKET FOR CELL BIOLOGY APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 131
TABLE 92 LATIN AMERICA: LIVE CELL IMAGING MARKET FOR CELL BIOLOGY APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 131
7.3 STEM CELLS 131
7.3.1 GROWING FOCUS ON REGENERATIVE MEDICINE & ADVANCEMENTS IN STEM CELL RESEARCH TO BOOST MARKET 131
TABLE 93 LIVE CELL IMAGING MARKET FOR STEM CELL APPLICATIONS, BY REGION, 2021–2028 (USD MILLION) 132
TABLE 94 NORTH AMERICA: LIVE CELL IMAGING MARKET FOR STEM CELL APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 132
TABLE 95 EUROPE: LIVE CELL IMAGING MARKET FOR STEM CELL APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 133
TABLE 96 ASIA PACIFIC: LIVE CELL IMAGING MARKET FOR STEM CELL APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 133
TABLE 97 LATIN AMERICA: LIVE CELL IMAGING MARKET FOR STEM CELL APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 133
7.4 DEVELOPMENTAL BIOLOGY 134
7.4.1 GROWING INTEREST IN UNDERSTANDING ORGANOGENESIS AND TISSUE MORPHOGENESIS TO DRIVE DEMAND 134
TABLE 98 LIVE CELL IMAGING MARKET FOR DEVELOPMENTAL BIOLOGY APPLICATIONS, BY REGION, 2021–2028 (USD MILLION) 134
TABLE 99 NORTH AMERICA: LIVE CELL IMAGING MARKET FOR DEVELOPMENTAL BIOLOGY APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 135
TABLE 100 EUROPE: LIVE CELL IMAGING MARKET FOR DEVELOPMENTAL BIOLOGY APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 135
TABLE 101 ASIA PACIFIC: LIVE CELL IMAGING MARKET FOR DEVELOPMENTAL BIOLOGY APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 135
TABLE 102 LATIN AMERICA: LIVE CELL IMAGING MARKET FOR DEVELOPMENTAL BIOLOGY APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 136
7.5 DRUG DISCOVERY 136
7.5.1 GROWING USE OF HCS CELL-BASED ASSAYS IN DRUG DISCOVERY STUDIES TO DRIVE DEMAND 136
TABLE 103 LIVE CELL IMAGING MARKET FOR DRUG DISCOVERY APPLICATIONS, BY REGION, 2021–2028 (USD MILLION) 137
TABLE 104 NORTH AMERICA: LIVE CELL IMAGING MARKET FOR DRUG DISCOVERY APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 137
TABLE 105 EUROPE: LIVE CELL IMAGING MARKET FOR DRUG DISCOVERY APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 138
TABLE 106 ASIA PACIFIC: LIVE CELL IMAGING MARKET FOR DRUG DISCOVERY APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 138
TABLE 107 LATIN AMERICA: LIVE CELL IMAGING MARKET FOR DRUG DISCOVERY APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 138
8 LIVE CELL IMAGING MARKET, BY TECHNOLOGY 139
8.1 INTRODUCTION 140
TABLE 108 LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 140
8.2 TIME-LAPSE MICROSCOPY 140
TABLE 109 LIVE CELL IMAGING MARKET FOR TIME-LAPSE MICROSCOPY, BY REGION, 2021–2028 (USD MILLION) 141
TABLE 110 NORTH AMERICA: LIVE CELL IMAGING MARKET FOR TIME-LAPSE MICROSCOPY, BY COUNTRY, 2021–2028 (USD MILLION) 141
TABLE 111 EUROPE: LIVE CELL IMAGING MARKET FOR TIME-LAPSE MICROSCOPY, BY COUNTRY, 2021–2028 (USD MILLION) 142
TABLE 112 ASIA PACIFIC: LIVE CELL IMAGING MARKET FOR TIME-LAPSE MICROSCOPY, BY COUNTRY, 2021–2028 (USD MILLION) 142
TABLE 113 LATIN AMERICA: LIVE CELL IMAGING MARKET FOR TIME-LAPSE MICROSCOPY, BY COUNTRY, 2021–2028 (USD MILLION) 142
8.3 FLUORESCENCE RESONANCE ENERGY TRANSFER (FRET) 143
8.3.1 ADVANCEMENTS IN FLUORESCENT MATERIALS AND PROBES TO BOOST ADOPTION OF FRET TECHNOLOGY 143
TABLE 114 LIVE CELL IMAGING MARKET FOR FLUORESCENCE RESONANCE ENERGY TRANSFER, BY REGION, 2021–2028 (USD MILLION) 143
TABLE 115 NORTH AMERICA: LIVE CELL IMAGING MARKET FOR FLUORESCENCE RESONANCE ENERGY TRANSFER, BY COUNTRY, 2021–2028 (USD MILLION) 143
TABLE 116 EUROPE: LIVE CELL IMAGING MARKET FOR FLUORESCENCE RESONANCE ENERGY TRANSFER, BY COUNTRY, 2021–2028 (USD MILLION) 144
TABLE 117 ASIA PACIFIC: LIVE CELL IMAGING MARKET FOR FLUORESCENCE RESONANCE ENERGY TRANSFER, BY COUNTRY, 2021–2028 (USD MILLION) 144
TABLE 118 LATIN AMERICA: LIVE CELL IMAGING MARKET FOR FLUORESCENCE RESONANCE ENERGY TRANSFER, BY COUNTRY, 2021–2028 (USD MILLION) 144
8.4 FLUORESCENCE RECOVERY AFTER PHOTOBLEACHING (FRAP) 145
8.4.1 INTEGRATION OF FRAP WITH LIVE CELL IMAGING MICROSCOPY TO CONTRIBUTE TO MARKET GROWTH 145
TABLE 119 LIVE CELL IMAGING MARKET FOR FLUORESCENCE RECOVERY AFTER PHOTOBLEACHING, BY REGION, 2021–2028 (USD MILLION) 145
TABLE 120 NORTH AMERICA: LIVE CELL IMAGING MARKET FOR FLUORESCENCE RECOVERY AFTER PHOTOBLEACHING, BY COUNTRY, 2021–2028 (USD MILLION) 146
TABLE 121 EUROPE: LIVE CELL IMAGING MARKET FOR FLUORESCENCE RECOVERY AFTER PHOTOBLEACHING, BY COUNTRY, 2021–2028 (USD MILLION) 146
TABLE 122 ASIA PACIFIC: LIVE CELL IMAGING MARKET FOR FLUORESCENCE RECOVERY AFTER PHOTOBLEACHING, BY COUNTRY, 2021–2028 (USD MILLION) 146
TABLE 123 LATIN AMERICA: LIVE CELL IMAGING MARKET FOR FLUORESCENCE RECOVERY AFTER PHOTOBLEACHING, BY COUNTRY, 2021–2028 (USD MILLION) 147
8.5 HIGH-CONTENT SCREENING (HCS) 147
8.5.1 GROWING ADOPTION OF HCS IN DRUG DISCOVERY AND TOXICITY SCREENING TO DRIVE GROWTH 147
TABLE 124 LIVE CELL IMAGING MARKET FOR HIGH-CONTENT SCREENING, BY REGION, 2021–2028 (USD MILLION) 148
TABLE 125 NORTH AMERICA: LIVE CELL IMAGING MARKET FOR HIGH-CONTENT SCREENING, BY COUNTRY, 2021–2028 (USD MILLION) 148
TABLE 126 EUROPE: LIVE CELL IMAGING MARKET FOR HIGH-CONTENT SCREENING, BY COUNTRY, 2021–2028 (USD MILLION) 148
TABLE 127 ASIA PACIFIC: LIVE CELL IMAGING MARKET FOR HIGH-CONTENT SCREENING, BY COUNTRY, 2021–2028 (USD MILLION) 149
TABLE 128 LATIN AMERICA: LIVE CELL IMAGING MARKET FOR HIGH-CONTENT SCREENING, BY COUNTRY, 2021–2028 (USD MILLION) 149
?
8.6 OTHER TECHNOLOGIES 149
TABLE 129 LIVE CELL IMAGING MARKET FOR OTHER TECHNOLOGIES, BY REGION, 2021–2028 (USD MILLION) 150
TABLE 130 NORTH AMERICA: LIVE CELL IMAGING MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2021–2028 (USD MILLION) 150
TABLE 131 EUROPE: LIVE CELL IMAGING MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2021–2028 (USD MILLION) 151
TABLE 132 ASIA PACIFIC: LIVE CELL IMAGING MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2021–2028 (USD MILLION) 151
TABLE 133 LATIN AMERICA: LIVE CELL IMAGING MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2021–2028 (USD MILLION) 151
9 LIVE CELL IMAGING MARKET, BY END USER 152
9.1 INTRODUCTION 153
TABLE 134 LIVE CELL IMAGING MARKET, BY END USER, 2021–2028 (USD MILLION) 153
9.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 153
9.2.1 NEED TO ADHERE TO STRICT REGULATIONS TO DRIVE USE OF LIVE CELL IMAGING PRODUCTS AMONG PHARMA COMPANIES 153
TABLE 135 LIVE CELL IMAGING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2021–2028 (USD MILLION) 154
TABLE 136 NORTH AMERICA: LIVE CELL IMAGING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION) 154
TABLE 137 EUROPE: LIVE CELL IMAGING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION) 155
TABLE 138 ASIA PACIFIC: LIVE CELL IMAGING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION) 155
TABLE 139 LATIN AMERICA: LIVE CELL IMAGING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION) 155
9.3 ACADEMIC & RESEARCH INSTITUTES 156
9.3.1 INCREASING NUMBER OF DRUG DISCOVERY RESEARCH PROGRAMS TO DRIVE MARKET GROWTH 156
TABLE 140 LIVE CELL IMAGING MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2021–2028 (USD MILLION) 156
TABLE 141 NORTH AMERICA: LIVE CELL IMAGING MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION) 157
TABLE 142 EUROPE: LIVE CELL IMAGING MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION) 157
TABLE 143 ASIA PACIFIC: LIVE CELL IMAGING MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION) 157
TABLE 144 LATIN AMERICA: LIVE CELL IMAGING MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION) 158
9.4 CONTRACT RESEARCH ORGANIZATIONS 158
9.4.1 GROWING OUTSOURCING OF R&D ACTIVITIES BY PHARMACEUTICAL COMPANIES TO DRIVE DEMAND 158
TABLE 145 LIVE CELL IMAGING MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2021–2028 (USD MILLION) 159
TABLE 146 NORTH AMERICA: LIVE CELL IMAGING MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 159
TABLE 147 EUROPE: LIVE CELL IMAGING MARKET FOR F CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 160
TABLE 148 ASIA PACIFIC: LIVE CELL IMAGING MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 160
TABLE 149 LATIN AMERICA: LIVE CELL IMAGING MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 160
10 LIVE CELL IMAGING MARKET, BY REGION 161
10.1 INTRODUCTION 162
TABLE 150 LIVE CELL IMAGING MARKET, BY REGION, 2021–2028 (USD MILLION) 162
10.2 NORTH AMERICA 162
FIGURE 30 NORTH AMERICA: LIVE CELL IMAGING MARKET SNAPSHOT 163
TABLE 151 NORTH AMERICA: LIVE CELL IMAGING MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 164
TABLE 152 NORTH AMERICA: LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 164
TABLE 153 NORTH AMERICA: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 164
TABLE 154 NORTH AMERICA: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION) 165
TABLE 155 NORTH AMERICA: LIVE CELL IMAGING MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 165
TABLE 156 NORTH AMERICA: LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 166
TABLE 157 NORTH AMERICA: LIVE CELL IMAGING MARKET, BY END USER, 2021–2028 (USD MILLION) 166
10.2.1 US 167
10.2.1.1 US to dominate live cell imaging market in North America 167
TABLE 158 US: LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 167
TABLE 159 US: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 168
TABLE 160 US: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION) 168
TABLE 161 US: LIVE CELL IMAGING MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 168
TABLE 162 US: LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 169
TABLE 163 US: LIVE CELL IMAGING MARKET, BY END USER, 2021–2028 (USD MILLION) 169
10.2.2 CANADA 169
10.2.2.1 Government initiatives to promote research to support market growth 169
TABLE 164 CANADA: LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 170
TABLE 165 CANADA: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 170
TABLE 166 CANADA: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION) 171
TABLE 167 CANADA: LIVE CELL IMAGING MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 171
TABLE 168 CANADA: LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 171
TABLE 169 CANADA: LIVE CELL IMAGING MARKET, BY END USER, 2021–2028 (USD MILLION) 172
10.2.3 NORTH AMERICA: RECESSION IMPACT 172
10.3 EUROPE 173
TABLE 170 EUROPE: LIVE CELL IMAGING MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 173
TABLE 171 EUROPE: LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 174
TABLE 172 EUROPE: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 174
TABLE 173 EUROPE: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION) 174
TABLE 174 EUROPE: LIVE CELL IMAGING MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 175
TABLE 175 EUROPE: LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 175
TABLE 176 EUROPE: LIVE CELL IMAGING MARKET, BY END USER, 2021–2028 (USD MILLION) 176
10.3.1 GERMANY 176
10.3.1.1 Presence of large number of academic research institutes to boost market 176
TABLE 177 GERMANY: LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 177
TABLE 178 GERMANY: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 177
TABLE 179 GERMANY: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION) 178
TABLE 180 GERMANY: LIVE CELL IMAGING MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 178
TABLE 181 GERMANY: LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 179
TABLE 182 GERMANY: LIVE CELL IMAGING MARKET, BY END USER, 2021–2028 (USD MILLION) 179
10.3.2 UK 180
10.3.2.1 Investments by pharmaceutical sponsors for drug discovery services to support market 180
FIGURE 31 UK: PHARMACEUTICAL R&D EXPENDITURE, 2011–2020 (USD MILLION) 180
TABLE 183 UK: LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 181
TABLE 184 UK: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 181
TABLE 185 UK: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION) 181
TABLE 186 UK: LIVE CELL IMAGING MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 182
TABLE 187 UK: LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 182
TABLE 188 UK: LIVE CELL IMAGING MARKET, BY END USER, 2021–2028 (USD MILLION) 183
10.3.3 FRANCE 183
10.3.3.1 Large pharmaceutical manufacturing industry to drive market growth 183
TABLE 189 FRANCE: LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 184
TABLE 190 FRANCE: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 184
TABLE 191 FRANCE: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION) 185
TABLE 192 FRANCE: LIVE CELL IMAGING MARKET, BY APPLICATION, 20



List of Tables

10.4 ASIA PACIFIC 196
TABLE 213 ASIA PACIFIC: LIVE CELL IMAGING MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 197
TABLE 214 ASIA PACIFIC: LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 197
TABLE 215 ASIA PACIFIC: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 198
TABLE 216 ASIA PACIFIC: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION) 198
TABLE 217 ASIA PACIFIC: LIVE CELL IMAGING MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 198
TABLE 218 ASIA PACIFIC: LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 199
TABLE 219 ASIA PACIFIC: LIVE CELL IMAGING MARKET, BY END USER, 2021–2028 (USD MILLION) 199
10.4.1 CHINA 200
10.4.1.1 China to dominate APAC live cell imaging market 200
TABLE 220 CHINA: LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 200
TABLE 221 CHINA: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 201
TABLE 222 CHINA: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION) 201
TABLE 223 CHINA: LIVE CELL IMAGING MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 201
TABLE 224 CHINA: LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 202
TABLE 225 CHINA: LIVE CELL IMAGING MARKET, BY END USER, 2021–2028 (USD MILLION) 202
10.4.2 JAPAN 202
10.4.2.1 Rising prominence of regenerative medicine research to drive market growth 202
TABLE 226 JAPAN: LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 203
TABLE 227 JAPAN: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 203
TABLE 228 JAPAN: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION) 204
TABLE 229 JAPAN: LIVE CELL IMAGING MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 204
TABLE 230 JAPAN: LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 205
TABLE 231 JAPAN: LIVE CELL IMAGING MARKET, BY END USER, 2021–2028 (USD MILLION) 205
10.4.3 INDIA 206
10.4.3.1 Growing pharmaceutical industry to create favorable opportunities for market players 206
TABLE 232 INDIA: LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 206
TABLE 233 INDIA: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 207
TABLE 234 INDIA: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION) 207
TABLE 235 INDIA: LIVE CELL IMAGING MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 207
TABLE 236 INDIA: LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 208
TABLE 237 INDIA: LIVE CELL IMAGING MARKET, BY END USER, 2021–2028 (USD MILLION) 208
10.4.4 REST OF ASIA PACIFIC (ROAPAC) 208
TABLE 238 REST OF ASIA PACIFIC: LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 209
TABLE 239 REST OF ASIA PACIFIC: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 210
TABLE 240 REST OF ASIA PACIFIC: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION) 210
TABLE 241 REST OF ASIA PACIFIC: LIVE CELL IMAGING MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 211
TABLE 242 REST OF ASIA PACIFIC: LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 211
TABLE 243 REST OF ASIA PACIFIC: LIVE CELL IMAGING MARKET, BY END USER, 2021–2028 (USD MILLION) 212
10.4.5 ASIA PACIFIC: RECESSION IMPACT 212
10.5 LATIN AMERICA 212
TABLE 244 LATIN AMERICA: LIVE CELL IMAGING MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 213
TABLE 245 LATIN AMERICA: LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 213
TABLE 246 LATIN AMERICA: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 214
TABLE 247 LATIN AMERICA: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION) 214
TABLE 248 LATIN AMERICA: LIVE CELL IMAGING MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 214
TABLE 249 LATIN AMERICA: LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 215
TABLE 250 LATIN AMERICA: LIVE CELL IMAGING MARKET, BY END USER, 2021–2028 (USD MILLION) 215
10.5.1 BRAZIL 216
10.5.1.1 Gradual growth in research to contribute to growth 216
TABLE 251 BRAZIL: LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 216
TABLE 252 BRAZIL: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 216
TABLE 253 BRAZIL: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION) 217
TABLE 254 BRAZIL: LIVE CELL IMAGING MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 217
TABLE 255 BRAZIL: LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 218
TABLE 256 BRAZIL: LIVE CELL IMAGING MARKET, BY END USER, 2021–2028 (USD MILLION) 218
10.5.2 REST OF LATIN AMERICA 219
TABLE 257 REST OF LATIN AMERICA: LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 219
TABLE 258 REST OF LATIN AMERICA: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 219
TABLE 259 REST OF LATIN AMERICA: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION) 220
TABLE 260 REST OF LATIN AMERICA: LIVE CELL IMAGING MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 220
TABLE 261 REST OF LATIN AMERICA: LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 221
TABLE 262 REST OF LATIN AMERICA: LIVE CELL IMAGING MARKET, BY END USER, 2021–2028 (USD MILLION) 221
10.5.3 LATIN AMERICA: RECESSION IMPACT 222
10.6 MIDDLE EAST & AFRICA 222
10.6.1 GROWING PHARMACEUTICAL INDUSTRY TO DRIVE MARKET GROWTH 222
TABLE 263 MIDDLE EAST & AFRICA: LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 223
TABLE 264 MIDDLE EAST & AFRICA: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 223
TABLE 265 MIDDLE EAST & AFRICA: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION) 223
TABLE 266 MIDDLE EAST & AFRICA: LIVE CELL IMAGING MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 224
TABLE 267 MIDDLE EAST & AFRICA: LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 224
TABLE 268 MIDDLE EAST & AFRICA: LIVE CELL IMAGING MARKET, BY END USER, 2021–2028 (USD MILLION) 225
10.6.2 MIDDLE EAST & AFRICA: RECESSION IMPACT 225
11 COMPETITIVE LANDSCAPE 226
11.1 INTRODUCTION 226
11.2 STRATEGIES ADOPTED BY KEY PLAYERS 227
FIGURE 32 LIVE CELL IMAGING MARKET: STRATEGIES ADOPTED BY KEY PLAYERS 227
11.3 REVENUE SHARE ANALYSIS 228
FIGURE 33 REVENUE ANALYSIS OF KEY PLAYERS, 2020–2022 228
11.4 MARKET SHARE ANALYSIS 228
FIGURE 34 MARKET SHARE ANALYSIS OF KEY PLAYERS, 2022 229
TABLE 269 LIVE CELL IMAGING MARKET: DEGREE OF COMPETITION 229
11.5 COMPANY EVALUATION QUADRANT: KEY PLAYERS 230
FIGURE 35 LIVE CELL IMAGING MARKET: COMPANY EVALUATION MATRIX FOR KEY PLAYERS, 2022 231
11.5.1 STARS 232
11.5.2 EMERGING LEADERS 232
11.5.3 PERVASIVE PLAYERS 232
11.5.4 PARTICIPANTS 232
11.6 COMPETITIVE BENCHMARKING OF TOP 25 PLAYERS 233
11.6.1 END-USER FOOTPRINT OF COMPANIES (25 COMPANIES) 233
TABLE 270 END-USER FOOTPRINT ANALYSIS OF KEY PLAYERS IN LIVE CELL IMAGING MARKET 233
11.6.2 PRODUCT & SERVICE FOOTPRINT OF COMPANIES (25 COMPANIES) 234
TABLE 271 PRODUCT & SERVICE FOOTPRINT ANALYSIS OF KEY PLAYERS IN LIVE CELL IMAGING MARKET 234
11.6.3 REGIONAL FOOTPRINT OF COMPANIES (25 COMPANIES) 235
TABLE 272 REGIONAL FOOTPRINT ANALYSIS OF KEY PLAYERS IN LIVE CELL IMAGING MARKET 235
11.7 COMPANY EVALUATION QUADRANT: START-UPS/SMES 236
FIGURE 36 LIVE CELL IMAGING MARKET: COMPANY EVALUATION MATRIX FOR START-UPS/SMES, 2022 236
11.7.1 PROGRESSIVE COMPANIES 237
11.7.2 STARTING BLOCKS 237
11.7.3 RESPONSIVE COMPANIES 237
11.7.4 DYNAMIC COMPANIES 237
11.8 COMPETITIVE BENCHMARKING OF START-UP/SME PLAYERS 237
TABLE 273 LIVE CELL IMAGING MARKET: DETAILED LIST OF KEY START-UP/SME PLAYERS 237
TABLE 274 LIVE CELL IMAGING MARKET: COMPETITIVE BENCHMARKING OF START-UP/SME PLAYERS 238
11.9 COMPETITIVE SCENARIO AND TRENDS 239
11.9.1 PRODUCT LAUNCHES 239
TABLE 275 LIVE CELL IMAGING MARKET: PRODUCT LAUNCHES, JANUARY 2020–DECEMBER 2022 239
11.9.2 DEALS 240
TABLE 276 LIVE CELL IMAGING MARKET: DEALS, JANUARY 2020–DECEMBER 2022 240
11.9.3 OTHER DEVELOPMENTS 241
TABLE 277 LIVE CELL IMAGING MARKET: OTHER DEVELOPMENTS, JANUARY 2020–DECEMBER 2022 241
12 COMPANY PROFILES 242
12.1 KEY COMPANIES 242
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
12.1.1 DANAHER 242
TABLE 278 DANAHER: BUSINESS OVERVIEW 242
FIGURE 37 DANAHER: COMPANY SNAPSHOT (2022) 243
12.1.2 ZEISS GROUP 247
TABLE 279 ZEISS GROUP: BUSINESS OVERVIEW 247
FIGURE 38 ZEISS GROUP: COMPANY SNAPSHOT (2022) 248
12.1.3 SARTORIUS AG 251
TABLE 280 SARTORIUS AG: BUSINESS OVERVIEW 251
FIGURE 39 SARTORIUS AG: COMPANY SNAPSHOT (2022) 252
12.1.4 THERMO FISHER SCIENTIFIC, INC. 254
TABLE 281 THERMO FISHER SCIENTIFIC, INC.: BUSINESS OVERVIEW 254
FIGURE 40 THERMO FISHER SCIENTIFIC, INC.: COMPANY SNAPSHOT (2022) 255
12.1.5 OLYMPUS CORPORATION 257
TABLE 282 OLYMPUS CORPORATION: BUSINESS OVERVIEW 257
FIGURE 41 OLYMPUS CORPORATION: COMPANY SNAPSHOT (2022) 258
12.1.6 PERKINELMER INC. 260
TABLE 283 PERKINELMER INC.: BUSINESS OVERVIEW 260
FIGURE 42 PERKINELMER INC.: COMPANY SNAPSHOT (2023) 261
12.1.7 NIKON CORPORATION 263
TABLE 284 NIKON CORPORATION: BUSINESS OVERVIEW 263
FIGURE 43 NIKON CORPORATION: COMPANY SNAPSHOT (2022) 264
12.1.8 ETALUMA, INC. 267
TABLE 285 ETALUMA, INC.: BUSINESS OVERVIEW 267
12.1.9 CYTOSMART TECHNOLOGIES 269
TABLE 286 CYTOSMART TECHNOLOGIES.: BUSINESS OVERVIEW 269
12.1.10 AGILENT TECHNOLOGIES, INC. 271
TABLE 287 AGILENT TECHNOLOGIES, INC.: BUSINESS OVERVIEW 271
FIGURE 44 AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2022) 272
12.1.11 NANOENTEK INC. 274
12.1.12 BECTON, DICKINSON AND COMPANY 275
TABLE 288 BECTON, DICKINSON AND COMPANY: BUSINESS OVERVIEW 275
FIGURE 45 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2022) 276
12.1.13 GE HEALTHCARE 277
TABLE 289 GE HEALTHCARE: BUSINESS OVERVIEW 277
FIGURE 46 GE HEALTHCARE: COMPANY SNAPSHOT (2022) 278
12.1.14 BRUKER CORPORATION 279
TABLE 290 BRUKER CORPORATION: BUSINESS OVERVIEW 279
FIGURE 47 BRUKER CORPORATION: COMPANY SNAPSHOT (2022) 280
12.1.15 MERCK KGAA 283
TABLE 291 MERCK KGAA: BUSINESS OVERVIEW 283
FIGURE 48 MERCK KGAA: COMPANY SNAPSHOT (2022) 284
12.1.16 BIO-RAD LABORATORIES, INC. 286
TABLE 292 BIO-RAD LABORATORIES, INC.: BUSINESS OVERVIEW 286
FIGURE 49 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2022) 287
12.1.17 CORNING INCORPORATED 288
TABLE 293 CORNING INCORPORATED: BUSINESS OVERVIEW 288
FIGURE 50 CORNING INCORPORATED: COMPANY SNAPSHOT (2022) 289
12.2 OTHER PLAYERS 290
12.2.1 BLUE-RAY BIOTECH CORP. 290
12.2.2 CYTENA GMBH 290
12.2.3 NANOLIVE SA 291
12.2.4 ABBERIOR 292
12.2.5 PHASE HOLOGRAPHIC IMAGING PHI AB 293
12.2.6 CYTOSKELETON, INC. 294
12.2.7 KEYENCE CORPORATION 295
12.2.8 ALIGNED GENETICS, INC. 296
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
13 APPENDIX 297
13.1 DISCUSSION GUIDE 297
13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 301
13.3 CUSTOMIZATION OPTIONS 303
13.4 RELATED REPORTS 304
13.5 AUTHOR DETAILS 305